McEwen Inc. and Canadian Gold Corp. Announce Closing of Arrangement

Toronto, Ontario and Flin Flon, Manitoba–(Newsfile Corp. – January 6, 2026) – McEwen Inc. (NYSE: MUX) (TSX: MUX) (“McEwen“) and Canadian Gold Corp. (TSXV: CGC) (“Canadian Gold“) are pleased to announce the completion of the previously announced business combination between McEwen and Canadian Gold by way of statutory plan of arrangement (the “Arrangement“). Shareholders of Canadian Gold […]

Sorrento Resources Engages Dr. Phillip Hellman as Technical Advisor

Vancouver, British Columbia–(Newsfile Corp. – January 6, 2026) – Sorrento Resources Ltd. (CSE: SRS) (OTCQB: SRSLF) (the “Company” or “Sorrento“) a Canadian exploration company focused on the acquisition, exploration, and development of mineral projects in Atlantic Canada, is pleased to announce that it has engaged Dr. Phillip Hellman as Technical Advisor to the Company. Dr. Phillip Hellman

Riverside Insights and Prometric Join Forces to Deliver Gold-Standard Assessments to International Markets

Riverside Insights and Prometric Join Forces to Deliver Gold-Standard Assessments to International Markets The partnership pairs Riverside's trusted, research-backed assessments with Prometric's global reach to give educators around the world clearer insight into each student's needs. GlobeNewswire January 06, 2026 ITASCA, Ill., Jan. 06, 2026 (GLOBE NEWSWIRE) — Riverside Insights, a leading provider of trusted,

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:BCRX), RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted one newly-hired employee restricted stock units (RSUs) covering an aggregate of 18,300 shares of BioCryst common stock. The RSUs were granted as of January 2, 2026, as

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire January 06, 2026 RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted one newly-hired employee restricted stock units (RSUs) covering an aggregate of 18,300 shares of BioCryst

Key Mining Corp., a Global Critical Minerals and Infrastructure Company, and Compass Digital Acquisition Corp. Announce Definitive Merger Agreement

(Other OTC:CDAQF),(OTC US:CDAQF), Key Mining Corp. (“KMC” or the “Company”) is a global critical minerals and infrastructure company focused on acquiring, advancing and developing assets in the Americas with projects in Chile and the United States. KMC owns 100% of the Cerro Blanco Titanium Project in Chile, the world's 10th largest rutile titanium dioxide deposit.1

Coda Octopus Group Sets Fiscal Year 2025 Earnings Conference Call for Thursday, January 29, 2026, at 10 a.m. Eastern Time

(NASDAQ:CODA), Orlando, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for real-time subsea intelligence and new generation augmented reality diving technology (“DAVD”), will host a conference call on Thursday, January 29, 2026 at 10:00

Aurora Mobile’s GPTBots.ai Partners with Echosens China to Improve Efficiency and Service Quality in Non-Invasive Liver Diagnostics

(NASDAQ:JG), SHENZHEN, China, Jan. 06, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its AI agent platform, GPTBots.ai, has established a strategic partnership with Echosens China. As medical technology rapidly permeates the healthcare sector,

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

(NASDAQ:ABP), FDA clearance enables initiation of Abpro's first clinical-stage solid tumor program Clinical trial anticipated to commence in the first half of 2026 through Abpro's global collaboration with Celltrion BURLINGTON, Mass. and INCHEON, South Korea, Jan. 06, 2026 (GLOBE NEWSWIRE) — Abpro Holdings, Inc. (Nasdaq: ABP), a biotechnology company developing next-generation antibody therapeutics for solid

Crown Crafts to Participate in the ICR Conference

(NASDAQ:CRWS), GONZALES, La., Jan. 06, 2026 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today announced that Olivia Elliott, President, Chief Executive Officer, and Claire Spencer, Chief Financial Officer, will be attending the ICR Conference in Orlando, Florida on Monday and Tuesday, January 12-13 and will present on Tuesday, January 13 at 1:00

Scroll to Top